An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis

VACCINE（2021）

引用 7|浏览0

暂无评分

摘要

•Phase 1 study of HEPLISAV-B in hemodialysis patients.•Four doses of HEPLISAV-B induced high level of seroprotection and were well tolerated.

查看译文

关键词

Hepatitis B vaccine, Toll-like receptor 9, Hemodialysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要